The global biotics market is expected to reach $105 billion by 2029, growing at a CAGR of 8.2%, up from $71 billion in 2024, a figure previously projected to reach $105 billion by 2030. This growth is attributed to two key factors: growing consumer awareness of the relationship between gut health and overall well-being, and a growing preference for preventative healthcare.

• North America is one of the fastest-growing markets, with high expectations in Mexico.

• Demand exceeds current supply, opening up expansion opportunities for distributors.

• Mexico represents 0.87% of the global market and South America 8.6%.

• The Asia-Pacific region has the largest share in the development and market of biotics.